Cargando…
Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
The pathomechanism of various autoimmune diseases is known to be associated with the altered function of programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) axis. We aimed to investigate the role of this pathway and inflammatory cell markers in subtypes of cutaneous lupus erythematos...
Autores principales: | Király, Zsófia, Szepesi, Ágota, Sebestyén, Anna, Kuroli, Enikő, Rencz, Fanni, Tóth, Béla, Bokor, Laura, Szakonyi, József, Medvecz, Márta, Hidvégi, Bernadett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377145/ https://www.ncbi.nlm.nih.gov/pubmed/35979531 http://dx.doi.org/10.3389/pore.2022.1610521 |
Ejemplares similares
-
The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus—A Pilot Study
por: Király, Zsófia, et al.
Publicado: (2023) -
Epidemiology and Treatment of Calcinosis Cutis: 13 Years of Experience
por: Róbert, Lili, et al.
Publicado: (2020) -
PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023) -
Anti-PD-1 Monotherapy in Advanced Melanoma—Real-World Data from a 77-Month-Long Retrospective Observational Study
por: Kuzmanovszki, Daniella, et al.
Publicado: (2022) -
Immunohistochemical Analysis of PD-1 and FOXP3 in Tumor-Infiltrating Lymphocytes in Human Gliomas
por: Kanagaraj, Priyanka, et al.
Publicado: (2023)